The transcriptional activity of the vitamin D receptor (VDR) is regulated by a number of coactivator and corepressor complexes, which bind to the VDR in a ligand (1,25(OH)2D3) dependent (coactivators) or inhibited (corepressors) process. In the keratinocyte the major coactivator complexes include the vitamin D interacting protein (DRIP) complex and the steroid receptor coactivator (SRC) complexes. Of the three SRC proteins critical for formation of SRC complexes, SRC3 plays the dominant role in keratinocytes. These coactivator complexes are not interchangeable in their regulation of keratinocyte proliferation and differentiation. We found that the DRIP complex is the main complex binding to VDR in the proliferating keratinocyte, whereas SRC3 and its associated proteins is the major coactivator binding to VDR in the differentiated keratinocyte. Moreover, we have found a specific role for DRIP205 in the regulation of wnt signaling pathways regulating keratinocyte proliferation, whereas SRC3 uniquely regulates the ability of 1,25(OH)2D3 to induce more differentiated functions such as lipid synthesis and processing required for permeability barrier formation and the innate immune response triggered by disruption of the barrier. These findings provide a basis by which we can understand how one receptor (VDR) and one ligand (1,25(OH)2D3) can regulate a large number of genes in a sequential and differentiation specific fashion. Furthermore, these observations indicate the potential for discovering small molecules that by selectively modulating the interactions between the coactivators and VDR can manifest specificity in regulating VDR function not achievable by ligands such as 1,25(OH)2D3 and its analogs. Hypothesis: The two main coactivator complexes, DRIP and SRC, differentially modulate the ability of VDR, its ligand 1,25(OH)2D3 and their interactions with 2-catenin to inhibit keratinocyte proliferation, while promoting keratinocyte differentiation leading to a protective epidermal barrier and normal hair follicle cycling. To test this hypothesis we have developed mice null for either DRIP205 or SRC3 that enable us to achieve the following aims.
Aim 1 Determine the selective roles of DRIP205 and SRC3 in VDR regulation of epidermal and hair follicle proliferation, differentiation, and protective barrier formation.
Aim 2. Determine the means by which DRIP205 and SRC3 modulate VDR/2-catenin interactions in their regulation of keratinocyte proliferation and differentiation of the epidermis and hair follicle.
Aim 3. Develop the means to selectively inhibit DRIP205 and SRC3 modulation of VDR function. Significance: Understanding the mechanisms by which 1,25(OH)2D3 regulates important functions of the epidermis including its proliferation and development of a protective barrier and developing the means to selectively modulate these functions is expected to have important therapeutic applications including the prevention of skin cancer and the development of treatment for a variety of skin diseases manifesting as hyperproliferation and disrupted differentiation.

Public Health Relevance

The mechanisms by which 1,25(OH)2D3 and its receptor VDR regulate keratinocyte differentiation and function remain unclear. We have discovered that different coactivators, DRIP and SRC in particular, regulate the transcriptional activity of VDR differently for different genes, and thus selectively affect different functions in the keratinocyte. By developing mice lacking either DRIP205 or SRC3, we will further explore these differences in an effort to more fully understand VDR transcriptional activity in the skin and develop means of selectively regulating these processes therapeutically.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-MOSS-A (02))
Program Officer
Baker, Carl
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Northern California Institute Research & Education
San Francisco
United States
Zip Code
Schwartz, Janice B; Gallagher, J Christopher; Jorde, Rolf et al. (2018) Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations. J Clin Endocrinol Metab 103:3278-3288
Malmstroem, Sofie; Rejnmark, Lars; Imboden, John B et al. (2017) Current Assays to Determine Free 25-Hydroxyvitamin D in Serum. J AOAC Int 100:1323-1327
Bikle, Daniel D; Malmstroem, Sofie; Schwartz, Janice (2017) Current Controversies: Are Free Vitamin Metabolite Levels a More Accurate Assessment of Vitamin D Status than Total Levels? Endocrinol Metab Clin North Am 46:901-918
Oda, Yuko; Hu, Lizhi; Nguyen, Thai et al. (2017) Combined Deletion of the Vitamin D Receptor and Calcium-Sensing Receptor Delays Wound Re-epithelialization. Endocrinology 158:1929-1938
Jassil, Navinder K; Sharma, Anupa; Bikle, Daniel et al. (2017) VITAMIN D BINDING PROTEIN AND 25-HYDROXYVITAMIN D LEVELS: EMERGING CLINICAL APPLICATIONS. Endocr Pract 23:605-613
Xie, Zhongjian; Yuan, Yuan; Jiang, Yi et al. (2017) p120-Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice. J Cell Physiol 232:1360-1367
Bikle, Daniel; Bouillon, Roger; Thadhani, Ravi et al. (2017) Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status? J Steroid Biochem Mol Biol 173:105-116
Yoshizaki, Keigo; Hu, Lizhi; Nguyen, Thai et al. (2017) Mediator 1 contributes to enamel mineralization as a coactivator for Notch1 signaling and stimulates transcription of the alkaline phosphatase gene. J Biol Chem 292:13531-13540
Bikle, Daniel D (2017) Vitamin D Prevents Sunburn: Tips for the Summer? J Invest Dermatol 137:2045-2047
Bikle, Daniel D (2016) Extraskeletal actions of vitamin D. Ann N Y Acad Sci 1376:29-52

Showing the most recent 10 out of 104 publications